Live Quote · NASDAQMBXHealthcare· Biotechnology

MBX Biosciences, Inc. Common Stock

$49.55▼ 7.23%($-3.86)
MKT CAP $2.46BNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
67
Valuation
20
Profitability
15
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBX research report →

Analyst Price Target
$97.67+97.1% vs. today

Range $84 – $150

Analyst RatingBuy
7 Buy0 Hold0 Sell

Price Chart

+87.79% · this period
$70.70$48.81$26.92Nov 20May 26Nov 20
52-Week Range50% of range
Low
$26.00
Current
$49.55
High
$72.64